| K-number | K221054 |
| Device name | CORE-INJECTOR |
| Applicant | Incore Co., Ltd. |
| Product code | FBK |
| Device class | Class II |
| Decision date | Dec 21, 2022 |
| Decision | Substantially Equivalent |
| Regulation | 876.1500 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov